?:authorAffiliation
|
-
[\'Department of Safety Evaluation and Risk Management, Epidemiology, GlaxoSmithKline Vaccines, Siena, Italy.\', \'Department and Laboratory of Intensive Care Medicine, University Hospitals and KU Leuven, Leuven, Belgium.\', \'Department of Infectious Diseases, Guy\'s and St Thomas\' NHS Foundation Trust, London, United Kingdom.\', \'Department of Cardiovascular Diseases, Research Unit of Cardiac Surgery, University Hospitals and KU Leuven.\']
|